Immunome, Inc. /
Morphimmune Inc.
Immunome completes merger with Morphimmune
What happened
Immunome, Inc. completed its merger with Morphimmune Inc. on October 2, 2023, with Morphimmune becoming a wholly owned subsidiary of Immunome. The transaction followed stockholder approval on September 29, 2023.
Morphimmune stockholders received Immunome common stock in exchange for their shares, with fractional shares paid in cash. Terms weren't disclosed.
The source
Everything on this page comes from the source below.
Immunome completes merger with Morphimmune
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Also stated
The source this page is built from.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly